Pancreatic Cancer Research

ResearcherUniversity of California San DiegoActive in the last 2 years

Jun Yamamoto

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-2591-5023; OpenAlex author ID A5012913698, A5029882515. Sources: OpenAlex.

Their work

Papers
5 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
13
Papers, trials and grants by year

2020: 1 paper · 2021: 1 paper · 2022: 1 paper · 2023: none · 2024: none · 2025: 1 paper · 2026: 1 paper

Papers 5

  1. High CDCP1 Expression Reflects Immune and Stromal Remodeling and Oncogenic Signaling in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.14740/wjon2682↗
  2. Methionine restriction inhibits pancreatic cancer proliferation while suppressing JAK2/STAT3 pathway. Co-author DOI 10.1016/j.pan.2024.11.023↗
  3. Stage IV Pancreatic Cancer Patient Treated With FOLFIRINOX Combined With Oral Methioninase: A Highly-Rare Case With Long-term Stable Disease. Co-author DOI 10.21873/anticanres.15734↗
  4. Triple-Methyl Blockade With Recombinant Methioninase, Cycloleucine, and Azacitidine Arrests a Pancreatic Cancer Patient-Derived Orthotopic Xenograft Model. First author DOI 10.1097/mpa.0000000000001709↗
  5. Oral recombinant methioninase increases TRAIL receptor-2 expression to regress pancreatic cancer in combination with agonist tigatuzumab in an orthotopic mouse… Co-author DOI 10.1016/j.canlet.2020.07.034↗

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Kentaro Miyake · 3 shared papers, 2020–2026 · strength 0.66
  2. Itaru Endo · 3 shared papers, 2020–2026 · strength 0.66
  3. Yuki Homma · 2 shared papers, 2020–2026 · strength 0.38
  4. Robert M. Hoffman · 3 shared papers, 2020–2022 · strength 0.38
  5. Masanori Oshi · 1 shared paper, 2026 · strength 0.29
  6. Manabu Maebashi · 1 shared paper, 2025 · strength 0.28
  7. Michael Bouvet · 2 shared papers, 2020–2021 · strength 0.21
  8. Hiroto Nishino · 2 shared papers, 2020–2021 · strength 0.21
  9. Norihiko Sugisawa · 2 shared papers, 2020–2021 · strength 0.21
  10. Yutaro Kubota · 1 shared paper, 2022 · strength 0.16
  11. Kei Kawaguchi · 1 shared paper, 2021 · strength 0.12
  12. Michiaki Unno · 1 shared paper, 2021 · strength 0.12
  13. Sant P. Chawla · 1 shared paper, 2020 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.